Implants

AcuityMD Signs Miach Orthopedics, Now Over 100 Medical Device Customers

AcuityMD’s data-driven commercial platform has helped device innovators identify more than 60,000 untapped healthcare professionals and over $6 billion in…

1 year ago

Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2023 and Provides Corporate Update

                  - Patient enrollment has commenced in landmark pivotal trial for lead product…

1 year ago

Capstan Medical Leverages Robotics to Bring Minimally Invasive Care to Heart Valve Patients

With $31.4 million in new funding, the company will bring the benefits of robotics to one of the few remaining…

1 year ago

Kuros Biosciences Reports Results for First Half 2023

Financial HighlightsDirect MagnetOs sales increased by 148% from CHF 4.9 million to CHF 12.2 million, total revenue from medical devices…

1 year ago

Establishment Labs Reports Record Second Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

1 year ago

Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc

- First of its kind, non-surgical, permanent birth control option begins enrollment in landmark trial -ATLANTA, Aug. 03, 2023 (GLOBE…

1 year ago

Global Transcatheter Heart Valve Market Set to Reach $15.14 Billion by 2030 with a Strong CAGR of 12.73% – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transcatheter Heart Valve Replacement Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company…

1 year ago

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control

FemBloc® patent application provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth controlATLANTA, July 27, 2023 (GLOBE…

1 year ago

Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023

IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing…

1 year ago

Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

1 year ago